Stocks
Intercept Pharmaceuticals (ICPT) EV/EBITDA US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -10.1 | -12.5 | -4.30 | -11.9 | -4.22 | -16.7 | ||
| Changes by years, y/y, % | +88% | +25% | -66% | +176% | -65% | -4.7% | |||
Intercept Pharmaceuticals. EV/EBITDA
Intercept Pharmaceuticals. EV/EBITDA, changes, %
Intercept Pharmaceuticals (ICPT) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | LTM ? | |||
| EV/EBITDA | ? | -2.01 | -7.50 | -6.94 | -6.98 | -16.2 | -16.7 | |
| Changes by years, y/y, % | -82% | +167% | +6% | +36% | +707% | |||
| Changes by quarters, q/q, % | -61% | +273% | -7% | +0% | +133% | |||
